Clinical Insights: January 15, 2018
Welcome to the weekly edition of RxStrategies Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. New Drug Approval No new updates. New Formulation Approval No new updates. New Indication Approval Lynparza® (olaparib) – January 12, 2018 – The Food and Drug Administration…
Connect with us at the 2017 CPCA Annual Conference!
Next week, on October 12-13 in Anaheim, California, the 2017 California Primary Care Association (CPCA) Annual Conference is taking place! Join RxS team members at the Hilton Anaheim for CPCA’s premier event providing opportunities to network with California’s community clinic and health center leaders while gaining insight into cutting-edge health care expertise and educational content. …
Ensuring Mission Achievement at the APHCA Annual Conference and Trade Show!
RxStrategies is proud to be a Platinum Level Sponsor of this year’s Alabama Primary Health Care Association (APHCA) 32nd Annual Conference and Trade Show, being held October 3-6 at the Perdido Beach Resort in Orange Beach, Alabama. This year’s focus is “Mission Achievement: All Systems Go,” and will inform and empower key decision makers and…
Clinical Insights: August 4, 2017
Welcome to the weekly edition of RxStrategies Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. New Drug Approval Vyxeos™ (cytarabine and daunorubicin) – August 3, 2017 – The U.S. Food and Drug Administration approved Vyxeos™ for the treatment of adults with two types of acute…
Clinical Insights: July 28, 2017
Welcome to the weekly edition of RxStrategies Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. New Drug Approval Vosevi™ (sofosbuvir/velpatasvir/voxilaprevir) – July 18, 2017 – The U.S. Food and Drug Administration approved Vosevi™ to treat adults with chronic hepatitis C virus (HCV) genotypes 1-6 without…
Clinical Insights: July 14, 2017
Welcome to the weekly edition of RxStrategies Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. New Drug Approval No new updates. New Indication Approval Blincyto® (blinatumomab) – New Expanded Indication Approval – July 11, 2017 – Amgen announced that the U.S. Food and Drug…
Clinical Insights: July 7, 2017
Welcome to the weekly edition of RxStrategies Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. New Drug Approval Endari™ (L-glutamine oral powder) – July 7, 2017 – The U.S. Food and Drug Administration approved Endari (L-glutamine oral powder) for patients age five years and older…
Clinical Insights: June 30, 2017
Welcome to the weekly edition of RxStrategies Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. New Drug Approval No new updates. New Indication Approval No new updates. New Drug Shortage June 21, 2017 Cromolyn Sodium Inhalation Solution, USP (Currently in Shortage) New…
Join RxStrategies at the 2016 GAPHC Annual Conference
Chief Operating Officer Time Vroman, Rhodie Smith and the RxStrategies team will be networking with community health center leaders during the GAPHC 2016 Annual Conference at the Grand Hyatt in Atlanta. This year’s conference will focus on the continuing advancements in healthcare for those serving Georgia’s medically underserved population. Ready to connect with a 340B…